Literature DB >> 14744727

p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review.

Anita Koushik1, Robert W Platt, Eduardo L Franco.   

Abstract

The Arg/Arg genotype versus Arg/Pro or Pro/Pro at codon 72 of the p53 gene has been implicated as a risk marker in cervical neoplasia. However, research on this topic has produced controversial results. We reviewed the published literature to summarize the association and to identify methodological features that may have contributed to the heterogeneity. Information on specific methodological features of studies addressing this topic published between 1998 and 2002 were obtained. Study-specific odds ratios (ORs) were combined in a meta-analysis, assuming random effects. To identify characteristics that significantly contributed to heterogeneity, we used meta-regression analysis. We identified 50 articles, of which 45 were included in the meta-analyses and regressions. No evidence of association or heterogeneity was detected for preinvasive lesions. For invasive cervical cancer with undefined histology, the Arg/Arg genotype was not found to affect risk (OR, 1.1; 95% confidence interval (CI), 0.9-1.3). However, a slightly increased risk was observed for squamous cell carcinoma (OR, 1.5; 95% CI, 1.2-1.9) and adenocarcinoma (OR, 1.7; 95% CI, 1.0-2.7). Meta-regression analysis identified that the most important factor contributing to heterogeneity among results for invasive lesions was departures from Hardy-Weinberg equilibrium in the control group. Summary ORs for studies in equilibrium were essentially null. A possible susceptibility role by the p53 codon 72 polymorphism at a late carcinogenetic stage in cervical cancer cannot be ruled out. However, various methodological features can contribute to departures from Hardy-Weinberg equilibrium and consequently to less than ideal circumstances for the examination of this polymorphism. Future investigations require appropriate attention to design and methodological issues.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14744727     DOI: 10.1158/1055-9965.epi-083-3

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  37 in total

1.  Polymorphisms of TP53 codon 72 with prostate carcinoma risk: a meta-analysis.

Authors:  Jing Zhang; Wen-Lei Zhuo; Ying Zheng; Yun-Song Zhang
Journal:  Med Oncol       Date:  2009-06-05       Impact factor: 3.064

2.  Lack of correlation between p53 codon 72 polymorphism and anal cancer risk.

Authors:  Simone S Contu; Grasiela Agnes; Andrea P Damin; Paulo C Contu; Mário A Rosito; Claudio O Alexandre; Daniel C Damin
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

3.  No significant association between p53 codon 72 Arg/Pro polymorphism and risk of oral cancer.

Authors:  Ning Jiang; Jie Pan; Lei Wang; Yin-Zhong Duan
Journal:  Tumour Biol       Date:  2012-11-29

4.  p53 codon 72 polymorphism and liver cancer susceptibility: a meta-analysis of epidemiologic studies.

Authors:  Xi Chen; Fei Liu; Bo Li; Yong-Gang Wei; Lv-Nan Yan; Tian-Fu Wen
Journal:  World J Gastroenterol       Date:  2011-03-07       Impact factor: 5.742

5.  Role of glutathione-S-transferase and codon 72 of P53 genotypes in epithelial ovarian cancer patients.

Authors:  Elaine Cristina Morari; Andre Bacellar Costa Lima; Natassia Elena Bufalo; Janaina Luisa Leite; Fabiana Granja; Laura Sterian Ward
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-19       Impact factor: 4.553

6.  TP53, MDM2, NQO1, and susceptibility to cervical cancer.

Authors:  Xiaoxia Hu; Zhengyan Zhang; Duanduan Ma; Phyllis C Huettner; L Stewart Massad; Loan Nguyen; Ingrid Borecki; Janet S Rader
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-03       Impact factor: 4.254

7.  Germline polymorphisms of glutathione-S-transferase GSTM1, GSTT1 and p53 codon 72 in cervical carcinogenesis.

Authors:  Masatsugu Ueda; Eisaku Toji; Osamu Nunobiki; Naomi Sato; Shinji Izuma; Kiyo Torii; Yoshiaki Okamoto; Sadamu Noda
Journal:  Hum Cell       Date:  2010-10-04       Impact factor: 4.174

8.  Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies.

Authors:  Tatiana Rabachini; Helen Trottier; Eduardo L Franco; Luisa L Villa
Journal:  BMC Genet       Date:  2010-05-26       Impact factor: 2.797

9.  Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited.

Authors:  Jill Koshiol; Allan Hildesheim; Paula Gonzalez; M Concepcion Bratti; Carolina Porras; Mark Schiffman; Rolando Herrero; Ana C Rodriguez; Sholom Wacholder; Meredith Yeager; Stephen J Chanock; Robert D Burk; Sophia S Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

10.  Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.

Authors:  Sophia S Wang; M Concepcion Bratti; Ana Cecilia Rodríguez; Rolando Herrero; Robert D Burk; Carolina Porras; Paula González; Mark E Sherman; Sholom Wacholder; Z Elizabeth Lan; Mark Schiffman; Stephen J Chanock; Allan Hildesheim
Journal:  J Infect Dis       Date:  2009-01-01       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.